David P. Schenkein - 20 May 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Director
Signature: /s/ William Cook, as Attorney in Fact for David Schenkein
Issuer symbol: AGIO
Transactions as of: 20 May 2022
Net transactions value: $0
Form type: 4
Filing time: 24 May 2022, 16:11:49 UTC
Previous filing: 23 Feb 2022
Next filing: 06 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGIO	Common stock	Options Exercise	$0	+1,585	+1.4%	$0.000000	117,879	20 May 2022	Direct
holding	AGIO	Common stock						79,082	20 May 2022	See footnote	F1
holding	AGIO	Common stock						270,772	20 May 2022	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGIO	Restricted stock unit	Options Exercise	$0	-1,585	-100%	$0.000000^*	0	20 May 2022	Common stock	1,585		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary.
F2	Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary.
F3	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F4	There restricted stock units were granted on May 20, 2021. The shares underlying these restricted stock units vest as to 100% of the underlying shares on May 20, 2022.